Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: If Moore took DL to court for this shouldn't we do likewise???
Sorry about the format, best I could do.... but the info thanks to BaNosser is an outrage!!
10.
The
MMP
portfolio
is
far
and
away
TPL's
most
valuable
portfolio
for
licensing
purposes.
Under
reasonable
royalty
analysis,
the
contributions
of
the
Fast
Logic,
Core
Flash
and
other
TPL
technologies
of
which
I
am
aware
are
minimal
relative
to
the
value
of
the
MMP
portfolio.
Allocating
less
than
20%
of
the
consideration
received
from
Apple
to
the
MMP
portfolio,
and
perrnitting
TPL
to
retain
80%
of
that
consideration
for
its
other
technologies,
would
be
absurd.
11.
I
regard
the
allocation
of
less
than
2A%
afthe
Apple
license
to
the
MMP
portfolio
to
be
a
breach
of
TPL's
fiduciary
duties
to
me
under
our
licensing

agreement

12.
I
am
extremely
concerned
that
TPL
will
continue
diverting
revenue
away
frorn
the
MMP
portfolio
to
its
other
portfolios
to
rninimize
its
monetary
obligations
to
me.
lf
TPL
has
changed
the
terms
of
the
Apple
deal
so
that
less
was
allocated
to
the
MMP
licenses,
over
a
quarter
of
the
diversion
would
have
impacted
me

personally

Share
New Message
Please login to post a reply